|

GEN1057 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Genmab1

Indications

  • Metastatic Malignant Solid Tumors1
  • Advanced Malignant Solid Tumors1
  • Cancer1

Nashville, Tennessee1 trial

Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors

SCRI Oncology Partners

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.